Although the article mentioned no specific company, the message is clear that we are in an area that will see increased demand in the coming years.
The report covered the shortage of genetic counselors for people who desire/need genetic testing. The story suggested that as a society we are indeed moving in the direction of more, not less, reliance upon genetic tests to determine our best course of prevention as well as treatment.
Not quite yet. But who knows what next will bring?
In any event, keep making those predictions. They really help us investors who are holding on the long side..
This news is fantastic, and it is exactly the direction I was hoping that the management would expand its professional staff. A few weeks ago I had suggested that a CMO would be the type of addition needed at CGEN, at least while we are still a science company and not yet a product company. The Strategic Advisor fills that role exactly. I know many here have been calling for a marketing executive, and that need will come eventually, but for now we need the medical voices like Pardoll and Sigal at the top to show the dedication and expertise of this company. This move is the best one I can think of to instill confidence in Wall Street and individual investors. My congratulations to all concerned.
Yes, again, I agree with the long term potential of this company. The short selling posters in this string are looking to make a quick trade, and have no regard for the concept of long term investing in companies that will provide life-saving products over the years.
Many negative posts have so much rancor and bitterness, all they seem to do is fume against the management. So many of their accusations are looking backward instead of forward.
No one has a crystal ball. We all read the same press releases and analyst reports. How we interpret them will always differ.
Excellent summary of all that has gone wrong with stock market. I agree completely. Thanks for taking the time to write this response.
This guy is undoubtedly the most blatant liar I have ever encountered on a message board. Check out his posts today in which he announces "I am out." Incredible.
Sadly, I've been a shareholder in other small biotech companies where exactly that process has happened. The company was sold right out from under us after a reverse split and dilution, and the corporate buyer could pay peanuts on our original investments. .
I have no idea if that is going on behind the scenes here, and I certainly hope you are wrong about it, but you are not out of the ball park with that suspicion. I understand that you are giving us your opinion, and I can follow your reasons for holding it. However, I detest the ad hominem comments that proliferate on this board. They are stupid, nearly insane, and meaningless. Give facts, not simple-minded attacks on individuals.
I had high hopes that this company would show its ability to survive and thrive with its science and products by now. Although I am still hoping to see some real success out of the management team during 2016, I would not recommend this stock to anyone. I am already at a horrendous loss here, and I am holding with some chance of regaining those losses, but if we do not see a strong turnaround in the next two or three quarters, I fear we never will. Nevertheless, I am willing to give the management team the remainder of the year to show the positive results we have been waiting for.
Oh, I hadn't realized it was that time of the quarter. Yes, that would account for the high volume at the very end of the session. Thanks, sydbiz.
As the saying goes, "The smart money buys in the last half hour." I'd sure like to know which "smart money" investor sold the ranch today and put the proceeds into CGEN.
As a strong opponent of the death penalty, I agree with your response to rootbound's analogy. But he hasn't provided any information that could be considered true or false. He rarely does. He is a trader/gambler who merely shouts on this MB as he would at a racetrack, urging his "horse" to run faster. Some traders think it will make a difference. Why shouldn't they? Delusional thinking makes the world go round.
Thanks, johnnador, and I apologize for any offense. One of my failings is a tendency to get "flip" when serious matters are under discussion.
I certainly understand your defense of a qualified spokesperson for the company, but I wonder if the job you describe would not be better filled by a Chief Medical Officer. In other companies I follow, the CMO has a medical degree, and thus understands both the research and the clinical application potential for any drug/product being studied.
BTW, I have not worked as a scientist (I have two undergraduate degrees, one in English the second in Mathematics with minimal hard science, and an ABD -- "all but dissertation" -- in English Lit), but I have worked for a large investment company, and I assure you that such institutional investors, like TR Price, have analysts with a strong science background, and their knowledge about the companies they invest in for their mutual funds is not superficial. The analysts I met and talked with really did not need a PR executive for the companies they invested in to explain the science. A Chief Medical Officer, however, I imagine would indeed provide the level of expertise they could rely on.
And,yes, I agree that we small fry individual investors would benefit by a clearer explanation of the company's science. However, I suspect the individual investor base for CGEN will remain small until we have a real product that has been proven effective. Even with a good PR executive, the company is just not going to matter much to hard-working individuals who want to see their investments placed in proven hands. Give them a product, however, and then hire the PR position to discuss it with the general population who will listen and appreciate the explanations.
Sorry to keep posting, but in the interest of full disclosure, I forgot to add one last company in my holdings, XOMA, which is at 31.72%.
The note-worthy point here is that the amount of institutional holdings reveals nothing about the success of the company vis-a-vis its share price. In fact, CGEN is the highest share price her, and trumps all the others in terms of its rise above the low for the year. All of these stocks are losers, but CGEN is best of them!
Yes, I often feel like I'm walking among the ruins of some once great civilization whenever I look at my holdings in XOMA.